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A B S T R A C T
Background: The risk for deterioration in patients receiving psychotherapy for adult depression has not been
examined extensively and it is not clear whether psychotherapy reduces this risk or may even increase it in some
patients. We conducted a meta-analysis of trials comparing these psychotherapies with control conditions that
report deterioration rates.
Methods: We used an existing database of randomized trials on psychotherapies for adult depression which was
updated up to 1/1/2017, through systematic searches in bibliographic databases. We included trials that re-
ported clinically significant deterioration rates.
Results: We included 18 studies with 23 comparisons between therapy and control groups. The pooled risk ratio
of deterioration was 0.39 (95% CI: 0.27∼0.57), indicating that patients in the psychotherapy groups have a 61%
lower chance to deteriorate than patients in the control groups. We found that 20 patients need to be treated
with psychotherapy in order to avoid one case of deterioration, compared to the control conditions. The median
deterioration rate in the therapy groups was 4%, and in some studies more than 10%, indicating that clinicians
should always be aware of the risk of deterioration.
Limitations: The results should be considered with caution because most studies had at least some risk of bias.
Only 6% of all trials comparing psychotherapy with a control condition reported deterioration rates, using
different ways to define deterioration which made pooling the prevalence rates across treatments and control
groups impossible.
Conclusions: Psychological treatments of adult depression may reduce the risk for deterioration, compared to
control groups, but this should be considered with caution because of the small proportion of studies reporting
deterioration rates.
1. Introduction
It is well-established that several types of psychotherapies are ef-
fective in the treatment of adult depression, including cognitive beha-
vior therapy (Cuijpers et al., 2016a), behavioral activation therapy
(Ekers et al., 2014), interpersonal psychotherapy (Cuijpers et al.,
2016b), problem-solving therapy (Malouff et al., 2007), and possibly
brief psychodynamic therapy (Driessen et al., 2015) and non-directive
counseling (Cuijpers et al., 2012). There is also considerable evidence
that the effects of these therapies do not or only marginally differ from
each other (Barth et al., 2013).
Apart from the average positive effects these therapies can have on
depressed patients, it is also important to examine whether these
therapies may have negative effects on some individual patients
(Barlow, 2010; Foulkes, 2010; Peterson et al., 2013). Although the
importance of negative effects of psychotherapies has been described
for several decades (Hadley and Strupp, 1976; Mohr, 1995), it is rela-
tively recent that this is considered one of the core issues that should be
prioritized in research on psychotherapies (Barlow, 2010; Lilienfeld,
2007). At the moment, it can be said that there is consensus in the field
of psychotherapy research that (1) negative effects should be examined
better and (2) has mostly been neglected in much of this research up to
now (Barlow, 2010; Dimidjian and Hollon, 2010).
How negative effects should be defined is less clear (Boisvert, 2010;
Dimidjian and Hollon, 2010). It is clear that an increased risk of dete-
rioration during therapy is one of the core types of negative effects.
However, there are other types of negative effects that are also im-
portant to consider, such as serious adverse events (Rozental et al.,
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2014). Also non-response and drop-out can be considered as negative
effects as they could have prevented the patient from receiving ade-
quate care or spontaneous remission (Dimidjian and Hollon, 2010). In
this paper we will focus on the negative effects of psychotherapies in
terms of clinically relevant deterioration, because this is one of the most
important type of negative outcomes, it has not been examined in
conventional meta-analyses before.
Although there is a considerable number of randomized trials that
report deterioration rates, to the best of our knowledge these have not
been integrated in meta-analytic research. There are some “individual
patient data” meta-analyses that have reported deterioration rates in
psychotherapies (Ebert et al., 2016; Vittengl et al., 2016). However,
these meta-analyses are aimed at only one type of treatment (internet-
based treatment of depression; (Ebert et al., 2016)), or focus on the
difference in deterioration rates between cognitive behavior therapy
and pharmacotherapy for depression (Vittengl et al., 2016). No meta-
analysis has examined deterioration rates in psychotherapy versus un-
treated control groups.
One important reason why no meta-analysis on deterioration rates
in psychotherapies has been conducted is that these deterioration rates
are typically not reported in titles and abstracts of studies, but only
reported in the full papers because this is typically not the primary
outcome of trials (only one of the 18 studies included in the current
meta-analysis reported negative outcomes in the abstract;
(Hautzinger et al. 2004)). At the same time only a relatively small
proportion of trials do report deterioration rates. Therefore, all papers
on trials in a certain field have to be collected and examined to de-
termine whether they report relevant data. In the current study we
solved this by using an existing database of randomized trials on psy-
chotherapies for adult depression that is updated every year and record
whether they report deterioration rates.
It has been estimated that 5–10% of patients deteriorate during
therapy (Lambert, 2007). However, that does not necessarily have to be
the result of the therapy, but may be related to other causes
(Dimidjian and Hollon, 2010). Therefore when assessing deterioration
rates in psychotherapy, it is important to compare these rates with
those in control groups.
In the current meta-analysis, we selected studies in which psy-
chotherapies for adult depression were compared with control condi-
tions (waiting list, care as usual, placebo, other inactive control group),
and examined whether they reported the number of patients who de-
teriorated (using any measure for deterioration). We then pooled the
results of these studies to estimate whether psychotherapy resulted in
lower or higher deterioration rates than the control conditions. We also
compared the characteristics of the patients, therapies and designs of
the studies that report deterioration rates with those that do not.
2. Methods
2.1. Identification and selection of studies
We used an existing database of studies on the psychological
treatment of depression. This database has been described in detail
elsewhere (Cuijpers et al., 2008b), and has been used in a series of
earlier published meta-analyses (Cuijpers, 2017). For this database we
searched four major bibliographical databases (PubMed, PsycInfo,
Embase and the Cochrane Library) by combining terms (both index
terms and text words) indicative of depression and psychotherapies,
with filters for randomized controlled trials. The full search string for
one database (PubMed) is given in Appendix A. We also searched a
number of bibliographical databases to identify trials in non-Western
countries (Cuijpers et al., 2018), because the number of trials on psy-
chological treatments in these countries is growing rapidly. Further-
more, we checked the references of earlier meta-analyses on psycho-
logical treatments of depression. The database is continuously updated
and was developed through a comprehensive literature search (from
1966 to January 1st 2017). All records were screened by two in-
dependent researchers and all papers that could possibly meet inclusion
criteria according to one of the researchers were retrieved as full-text.
The decision to include or exclude a study in the database was also done
by the two independent researchers, and disagreements were solved
through discussion.
We included studies that were: (a) a randomized trial (b) on a
psychological treatment (c) for adult depression that was (d) compared
with a control group (waiting list, care-as-usual, placebo, other inactive
treatment) (e) and reported deterioration rates for the psychological
treatment and the control group. Depression could be established with a
diagnostic interview or with a score above a cut-off on a self-report
measure. Psychotherapy was defined as an intervention with a primary
focus on language-based communication between a patient and a
therapist, or as bibliotherapy supported by a therapist (Barth et al.,
2013). We allowed any definition of clinically significant deterioration,
as long as it indicated the proportion of patients in therapy and control
groups who scored higher on depression symptom severity after treat-
ment than they did at baseline, and as long as the authors described this
as an indication for clinically significant deterioration. Co-morbid
mental or somatic disorders were not used as an exclusion criterion.
Studies on inpatients were excluded. We also excluded maintenance
studies, aimed at people who had already recovered or partly recovered
after an earlier treatment. In order to compare the characteristics of the
studies that reported deterioration rates and those that did not, we also
included studies that met all inclusion criteria, except (e) and did not
report deterioration rates.
2.2. Quality assessment and data extraction
We assessed the validity of included studies using four criteria in-
spired by the ‘Risk of bias’ assessment tool, developed by the Cochrane
Collaboration (Higgins et al., 2011). This tool assesses possible sources
of bias in randomized trials, including the adequate generation of al-
location sequence; the concealment of allocation to conditions; the
prevention of knowledge of the allocated intervention (masking of as-
sessors); and dealing with incomplete outcome data (this was assessed
as positive when intention-to-treat analyses were conducted, meaning
that all randomized patients were included in the analyses). Assessment
of the validity of the included studies was conducted by two in-
dependent researchers, and disagreements were solved through dis-
cussion.
We also coded participant characteristics (recruitment: community,
clinical, other; diagnosis: according to a diagnostic interview or a self-
report measure; target group: adults in general or a specific target
group, such as older adults, patient with a comorbid general medical
disorder or women with postpartum depression); characteristics of the
psychotherapies (type of therapy: CBT versus another therapy; treat-
ment format: individual, group, guided self-help, other; number of
sessions); and general characteristics of the studies (type of control
group: waiting list, care as usual, other; risk of bias; year of publica-
tion).
2.3. Outcome measures
For each comparison between a psychotherapy and a control con-
dition, we calculated the risk ratio (RR), indicating the proportion of
patients that deteriorated in the therapy group, divided by the pro-
portion in the control group. A RR of 1 indicates that the proportion of
deteriorated patients in the therapy group is the same as the proportion
in the control group, a RR below 1 indicates that the proportion of
deteriorated patients is lower in the treatment group. Conversely, a RR
above 1 indicates the proportionis higher in the treatment group.
We also calculated the risk difference (RD), which indicates the
difference between the proportion of deterioration in the therapy group
and the control group. We used the RD to calculate the numbers-
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needed-to-be-treated (NNT), which indicates the number of patients
that have to be treated in order to avoid one case of deterioration (the
NNT is 1 divided by the RD).
2.4. Meta-analyses
To calculate pooled RRs and RDs, we used the computer program
Comprehensive Meta-Analysis (version 3.3070; CMA). Because we ex-
pected considerable heterogeneity among the studies, we employed a
random effects pooling model in all analyses. As a test of homogeneity
of effect sizes, we calculated the I2-statistic, which is an indicator of
heterogeneity in percentages. A value of 0% indicates no observed
heterogeneity, and larger values indicate increasing heterogeneity, with
25% as low, 50% as moderate, and 75% as high heterogeneity
(Higgins et al., 2003). We calculated 95% confidence intervals around
I2 (Ioannidis et al., 2007), using the non-central chi-squared-based ap-
proach within the heterogi module for Stata (Orsini et al., 2006).
We conducted subgroup analyses according to the mixed effects
model, in which studies within subgroups are pooled with the random
effects model, while tests for significant differences between subgroups
are conducted with the fixed effects model. Because the number of
studies was relatively small, we conducted only subgroup analyses for
the most basic characteristics of the patients (whether or not depression
was established with a diagnostic interview), the interventions (type of
therapy: CBT versus other therapies; format: individual, group or
guided self-help) and the studies (type of control group: waiting list,
care as usual, other), as well as the definition of deterioration..
We conducted sensitivity analyses to examine whether risk of bias
was associated with the outcomes. We compared studies with low risk
of bias (no bias on any of the four items) to studies with risk of bias
according to at least one of the items.
For continuous variables, we used meta-regression analyses to test
whether there was a significant relationship between the continuous
variable and effect size, as indicated by a Z-value and an associated p-
value. Multivariate meta-regression analyses, with the effect size as the
dependent variable, were conducted in CMA.
We tested for publication bias by inspecting the funnel plot on
primary outcome measures and by Duval and Tweedie's trim and fill
procedure (Duval and Tweedie, 2000), which yields an estimate of the
effect size after the publication bias has been taken into account (as
implemented in CMA). We also conducted Egger's test of the intercept
to quantify the bias captured by the funnel plot and to test whether it
was significant.
2.5. Comparisons between studies that did and did not report deterioration
rates
In order to examine whether the participants, interventions and
general characteristics of the studies reporting deterioration rates dif-
fered from that did not report them, we compared basic characteristics
of the two samples. We compared the two samples of studies with chi-
square tests for categorical variables and with t-tests for continuous
variables. These analyses were done with SPSS, version 23.
3. Results
3.1. Selection and inclusion of studies
After examining a total of 18,500 abstracts during the building of
the database described in the Methods section (14,290 after removal of
duplicates), we retrieved 2092 full-text papers for further considera-
tion. We excluded 2074 of the retrieved papers. The PRISMA flowchart
describing the inclusion process, including the reasons for exclusion, is
presented in Fig. 1. A total of 18 studies with 23 comparisons between a
therapy and a control group met inclusion criteria for this meta-analysis
(Table 1).
For the comparison between studies that reported deterioration
rates and those that did not, we included another 271 studies with 346
comparisons between a therapy and a control group, that met all in-
clusion criteria, except that deterioration rates were not included. The
references and characteristics of the studies are given in another paper
(Cuijpers et al., 2018). Among the total sample of studies (N=289)
only 6.2% (N=18) reported deterioration rates.
3.2. Characteristics of included studies
Selected characteristics of the included studies are presented in
Table 1. The 18 studies with 23 comparisons between a therapy and a
control group included a total of 1655 patients (519 in the CBT inter-
vention groups, 350 in the other intervention groups, 329 in the waiting
list control groups, 294 in the care-as-usual control groups and 163 in
the other control groups). A total of six studies were aimed at adults in
general and 12 at other more specific target groups. Twelve studies
recruited patients (also) from the community, three recruited ex-
clusively from clinical populations, three used other recruitment
methods. Nine studies with 12 comparisons used a diagnostic measure
to diagnose a depressive disorder, while nine studies with 11 compar-
isons used clinical cut-off scores. Treatment was delivered in individual
format in five studies with six comparisons, in group format in seven
studies with 11 comparisons, and in guided self-help format in six
studies with six comparisons. The number of treatment sessions ranged
from six to 12. In 10 studies with 13 comparisons a waiting list control
group was used, five studies with five comparisons had a care-as-usual
control group, and three studies with five comparisons used another
control group. Five studies were conducted in the United States of
America, two in Canada, three in Australia, three in Germany, two in
Sweden, one in China, one in Finland and one in the United Kingdom.
Deterioration was measured using the criteria for clinically significant
deterioration by Jacobson and Truax (1991) in 11 studies, while 7
studies used another definition (such as moving to another symptom
category or scoring a number of points lower on a depression scale).
3.3. Quality ratings
The quality of the studies varied. Nine studies reported an adequate
sequence generation, while the other nine did not. Six studies reported
allocation to conditions by an independent (third) party. Five studies
reported blinding of outcome assessors while another 12 used only self-
report outcomes. A total of 11 studies conducted intention-to-treat
analyses. Only three studies met all four quality criteria, seven met
three criteria, two met two criteria, and the remaining six studies met
one of the criteria.
3.4. Deterioration rates of psychotherapies compared to control groups
The pooled risk ratio (RR) of deterioration rates in all 23 compar-
isons between a psychotherapy and control group was RR=0.39 (95%
CI: 0.27–0.57), with zero heterogeneity (I2=0; 95% CI: 0–40). This
means that the risk for deterioration in the psychotherapy groups was
reduced by 61% compared to the control groups. The risk difference
(RD) between psychotherapy and control groups, which indicates the
risk of deterioration in the control groups minus the risk in the psy-
chotherapy groups, was RD=0.05 (95% CI: 0.03–0.07), which corre-
sponds with a numbers-needed-to-be-treated (NNT) of 20. The forest
plot with the RRs, RDs and the exact number of deteriorated patients in
each study is presented in Fig. 2. The deterioration rates in the psy-
chotherapy groups ranged from 0 to 25%, with a median of 4%. The
deterioration rates in the control conditions ranged from 1 to 44% with
a median of 11%.
As can be seen from Fig. 2, the majority of trials did not result in
significant differences between the treatment and control groups in
terms of deterioration. Only three of the 23 comparisons were
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significant, which is not surprising considering the small number of
patients that deteriorated and low statistical power in each study.
In four studies, two or more types of therapies were compared with
the same control group (three studies with two comparisons, and one
with three comparisons). Because these effect sizes were not in-
dependent of each other, they may have artificially reduced hetero-
geneity and influenced the outcomes. We conducted two separate
analyses to examine this. In the first analysis we only included the
largest effect size from each study in the pooling of the outcomes, and
in the second only the smallest effect size. As can be seen in Table 2, the
effect sizes and levels of heterogeneity were comparable to those in the
main analyses.
We found no indication for publication bias. Duvall and Tweedie's
trim and fill procedure did not indicate that studies were missing (the
adjusted RR was identical to the original RR), and Egger's test of the
intercept was not significant (p>0.1).
We conducted a series of subgroup analyses to examine possible
associations of the RR with characteristics of the participants, therapies
and the studies. Because the number of studies was not large, we lim-
ited these analyses to some of the most essential ones (Table 2). We
found no indications that the RR was associated with the definition of
depression (according to a diagnostic interview versus a high score on a
self-rating depression measure), type of therapy (CBT versus others),
treatment format (individual, group, guided self-help), and type of
control group (waiting list, care as usual, other).
We examined risk of bias in sensitivity analyses in which we ex-
amined potential differences between studies with no risk of bias
compared to studies with any risk of bias (Table 2). We found no in-
dication that studies with low risk of bias had different outcomes than
the other studies, although the number of studies with low risk of bias
was small and not finding a significant difference may be related to low
statistical power.
Fig. 1. Flowchart for the inclusion of studies.
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3.5. Differences between studies that did and did not report deterioration
rates
The characteristics of the participants, therapies and design of the
studies that reported deterioration rates and those that did not are re-
ported in Table 3. There were no significant differences between the
two samples of studies.
4. Discussion
In this meta-analysis we pooled the deterioration rates reported in
randomized trials of psychotherapies for adult depression. We found
that psychotherapy significantly reduces deterioration rates of patients
compared to patients in control conditions. Overall, we found that the
risk of deterioration in the psychotherapy groups was reduced by 61%
compared to untreated control conditions. We found that 20 patients
need to be treated with psychotherapy in order to avoid one case of
deterioration, compared to the control conditions.
Heterogeneity was zero in the studies reporting deterioration rates,
suggesting that all studies point in the same direction, although the
95% CI around the level of heterogeneity is too large to draw definite
conclusions about that. The low level of heterogeneity is in contrast
with other meta-analyses examining the effects of psychotherapies on
depressive symptoms (e.g., Cuijpers et al., 2013; Cuijpers et al., 2016a).
However, the number of trials reporting deterioration rates was low and
it is not clear whether the studies that do report these rates are re-
presentative of all trials on psychotherapy for depression. Overall, only
6% of all trials comparing psychotherapy for depression with a control
group, reported the deterioration rate.
That only 6% of trials report deterioration rates is concerning. The
need for research on negative effects has been acknowledged for several
years now (Barlow, 2010; Foulkes, 2010; Peterson et al., 2013), but
even in recent trials negative outcomes are usually not reported. In the
141 randomised controlled trials on psychotherapy for adult depres-
sion, only 8% reported deterioration rates.
One reason why authors do not report negative outcomes in trials
may be that these outcomes do not significantly differ between treat-
ment and control groups. Because usually only a small numbers of
patient deteriorate, there is typically not enough statistical power to
detect significant differences between treatment and control groups.
Authors may think that it is not important enough to report such out-
comes because of the non-significance. However, whether or not out-
comes are significant should not be leading in reporting outcomes of
trials. Even if differences between therapy and control groups on ne-
gative outcomes are not significant, they should be reported in rando-
mized trials, because these outcomes can be pooled in meta-analyses
and still result in important knowledge about the negative outcomes
and predictors of such outcomes.
While the mean risk for deterioration was reduced compared to the
control group, it may nevertheless be the case that patients with certain
Table 1
Selected characteristics of randomized trials of psychotherapies for adult depression reporting deterioration rates (N=18).
Study Type Recr Target grp Diagn Conditions N Nsess Format Country RoBa
Buntrock et al. (2015) CBT Comm Adults Subthr. Depr.;
CES-D≥ 16
iCBT CAU 202 204 6 gsh Germany ++++
Carlbring et al. (2013) Other Comm Adults MDD: DSM-IV, SCID iBA+ACT WL 40 40 7 gsh Sweden ++SR +
Choy (2016) Other Other Elderly Cut–off; GDS–15–Ch 8–13 Instr. RT WL 39 33 8 grp China – – SR –
Gitlin et al. (2013) Other Comm Elderly Cut-off; PHQ-9≥ 5 Home-B I WL 89 93 10 ind USA ++SR +
Hallford (2016) Other Clin Adults Cut-off; DASS-21-SF≥ 7 CRT CAU 14 12 6 ind Australia –+SR +
Hautzinger (2004) CBT Comm Elderly Unipolar Depr; DSM-IV,
SCID
CBT WL 65 35 12 grp Germany + – SR +
Kelly et al. (1993) CBT/SUP Comm Gen. Med. Cut-off; CES-D≥ 16 CBT SUP Comp.
Cond.
27 14 27 8 grp USA – – SR –
Lappalainen et al. (2015) Other Comm Adults MDE; DSM-IV-TR iACT WL 18 20 6 gsh Finland –+SR +
Mulcahy et al. (2010) IPT Clin Women with
PPD
MDD; DSM-IV, MCMI-III IPT CAU 23 27 11 grp Australia + – – –
Nobis et al. (2015) CBT Comm Gen. Med. Cut-off; CES-D≥ 23 iCBT Psychoed. 129 127 6 gsh Germany + – SR +
Pugh et al. (2015) CBT Comm Women with
PPD
Cut-off; EPDS≥ 10 iCBT WL 24 21 12 gsh Canada ++SR –
Ransom et al. (2008) IPT Comm Gen. Med. MDE / Dysth.; PRIME-MD IPT CAU 31 35 6 ind USA – – SR +
Scott and Stradling (1990) CBT Clin Adults Primary / Probable MDD;
RDC, PSE
CBT – gct CBT – ict
WL
10 19 19 12 Grp ind UK – – SR +
Segre et al. (2015) Other Other Other Cut-off; EPDS≥ 12 LV WL 41 25 6 ind USA + –++
Watt and Cappeliez (2000) Other Comm Elderly Cut-off; GDS≥ 14 Instr. RT Integr. RT
Active Soc.
9 9 9 6 grp Canada – –+ –
Wickberg and Hwang (1996) SUP Other Women with
PPD
MDD; DSM-III-R, MADRS SUP CAU 15 16 6 ind Sweden – –+ –
Wollersheim and
Wilson (1991)
CBT Comm Adults MDD; DSM-III,
MMPI≥ 70
CBT – cop CBT – gsh
SUP WL
8 8 8 8 10 Grp gsh grp USA – – SR –
Wuthrich and Rapee (2013) CBT Comm Elderly Anx/Mood Dis; DSM-IV,
ADIS
CBT WL 27 35 12 grp Australia + –++
Abbreviations: ACT: acceptance and commitment therapy; Anx: anxiety; AU: Australia; CAN: Canada; CAU: care as usual; CBT: cognitive behavioral therapy; CES-D:
center for epidemiological studies depression scale; Clin: participants recruited in a clinical setting; Comm: participants recruited in a community setting; Comp.
Cond.: comparison condition; CRT: cognitive-reminiscence therapy; CT: cognitive therapy; DASS-21-SF: depression anxiety and stress scale 21-item short-form;
Diagn: diagnosis; Dis: disorder; Dysth.: dysthymic disorder; EU: Europe; GDS: geriatric depression scale; GDS-15-Ch: geriatric depression scale short form Chinese
version; Gen. Med.: general medical disorder; Grp: group format; Gsh: guided self-help format; Home-B I: home-based intervention; iACT: web-based acceptance and
commitment-based therapy; iBA: internet-based behavioral activation; iCBT: web-based cognitive behavioral intervention; Ind: individual format; Instr. RT: in-
strumental reminiscence therapy; Integr. RT: integrative reminiscence therapy; LV: listening visits; MCMI-III: Millon clinical multiaxial inventory-III; MDD: major
depressive disorder; MDE: major depressive episode; Nsess: number of sessions; PHQ-9: patient health questionnaire; PPD: post-partum depression; PRIME-MD:
primary care evaluation of mental disorders, Mood Module; PSE: present state examination; Psychoed: psychoeducation; Recr: recruitment; RDC: Spitzer's research
diagnostic criteria; RoB: risk of bias; Soc: socialization; Subthr. Depr.: subthreshold depression; SUP: nondirective supportive therapy; UK: United Kingdom; USA:
United States of America; WL: waitlist.
a) In this column a positive (+) or negative (−) sign is given for four quality criteria of the study, respectively: allocation sequence; concealment of allocation to
conditions; blinding of assessors; and intention-to-treat analyses. Sr in the third criterion indicates that only self-report measures (and no assessor) were used.
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characteristics experience a deterioration as a consequence of the
therapy. Individual patient data (IPD) meta analyses can conduct ana-
lyses that have not been reported by the primary studies. For example,
one recent IPD meta-analysis of trials on internet-based treatments of
depression also found lower deterioration rates for patients receiving
treatment compared to control groups, but also found that patients with
lower education had a higher risk for deterioration than patients with
higher education (Ebert et al., 2016). Hence, future studies should use
such approaches in order to identify subgroups that might experience a
worse adjustment as a result of the treatment.
The results of this study are in line with a growing number of meta-
analytic studies showing that psychological treatments result in a
significant reduction of deterioration in patients. Earlier studies were
limited to small samples (Vittengl et al., 2016), and one type of inter-
vention (internet-based CBT; (Ebert et al., 2016)). However, these
studies also support the findings that deterioration rates are low and
that psychological treatment reduces these rates.
Deterioration rates are low in most studies, but it depends on how it
is measured. In some studies the deterioration rates are higher than
10% in the therapy groups. That means that deterioration is something
that therapists should always be cautious about. It cannot be expected
that therapies work for everyone and that all patients improve during
therapy. Therapists should be trained in recognition and evaluation of
deterioration and other negative effects of therapy, as well as how to
Rates a)
Study Definition of deterioration RR 95% CI p n/Npsy n/Nctr RR (95% CI) RD 95% CI
Buntrock, 2015 clin sign deterioration b) 0.34 0.15~0.77 0.01 7/202 21/204 0.07 0.02~0.12
Carlbring, 2013 increase in BDI with >10 1.00 0.02~49.17 1.00 1/40 1/40 0.00 -0.05~0.05
Choy, 2016 worsening GDS (to higher sympt. cat.) 0.17 0.01~3.42 0.25 0/39 2/33 0.06 -0.03~0.15
Gitlin, 2013 worsening PHQ (to higher sympt. cat.) 0.47 0.17~1.31 0.15 5/89 11/93 0.06 -0.02~0.14
Hallford, 2016 clin sign deterioration b) 0.43 0.04~4.16 0.47 1/14 2/12 0.10 -0.16~0.35
Hautzinger, 2004 One SD change (GDS / IDS) 0.09 0.01~0.72 0.02 1/65 6/35 0.16 0.03~0.28
Kelly, 1993 – cbt Deterioration c) 0.50 0.20~1.27 0.14 5/27 10/27 0.19 -0.05~0.42
Kelly, 1993 – sup Deterioration c) 0.39 0.10~1.52 0.17 2/14 10/27 0.23 -0.03~0.49
Lappalainen, 2015 clin sign deterioration b) 1.11 0.02~53.16 0.96 1/18 1/20 0.00 -0.10~0.10
Mulcahy, 2010 deteriorated (>4 points incr. on EPDS) 0.17 0.01~3.07 0.23 0/23 3/27 0.11 -0.02~0.25
Nobis, 2015 clin sign deterioration b) 0.12 0.02~0.97 0.05 1/129 8/127 0.06 0.01~0.10
Pugh, 2015 clin sign deterioration b) 0.18 0.01~3.47 0.25 0/24 2/21 0.10 -0.05~0.24
Ransom, 2008 clin sign deterioration b) 1.13 0.07~17.30 0.93 1/31 1/35 0.00 -0.09~0.08
Scott, 1990 – gct clin sign deterioration b) 0.61 0.03~13.66 0.75 0/10 1/19 0.05 -0.12~0.22
Scott, 1990 – ict clin sign deterioration b) 0.33 0.01~7.70 0.49 0/19 1/19 0.05 -0.08~0.19
Segre, 2015 clin sign deterioration b) 0.21 0.01~4.88 0.33 0/41 1/25 0.04 -0.06~0.14
Watt, 2000 – instr clin sign deterioration b) 0.22 0.02~2.70 0.24 0/9 2/9 0.28 -0.07~0.62
Watt, 2000 – integr clin sign deterioration b) 0.22 0.02~2.70 0.24 0/9 2/9 0.28 -0.07~0.62
Wickberg, 1996 worsening (MADRS change >10) 0.21 0.01~4.10 0.30 0/15 2/16 0.13 -0.06~0.31
Wollersheim, 1991 – cop clin sign deterioration b) 1.00 0.18~5.46 1.00 2/8 2/8 0.00 -0.42~0.42
Wollersheim, 1991 – gsh clin sign deterioration b) 0.50 0.06~4.47 0.54 1/8 2/8 0.13 -0.25~0.50
Wollersheim, 1991 – sup clin sign deterioration b) 0.50 0.06~4.47 0.54 1/8 2/8 0.13 0.25~-0.50
Wuthrich, 2013 clin sign deterioration b) 1.30 0.08~19.80 0.85 1/27 1/35 0.01 -0.10~0.08
Pooled 0.39 0.27~0.57 0.00 0.05 0.03~0.07
0.01          0.1            1.0          10.0
Abbreviations: BDI: Beck’s Depression Inventory; Cat: Category; CBT: Cognitive Behavioral Therapy; CI: Confidence interval; Clin Sig: Clinical significant; Cop: Coping 
Therapy; EPDS: Edinburgh Postnatal Depression Scale; Gct: Group Cognitive Therapy; GDS: Geriatric Depression Scale; Gsh: Guided self-help; HAMD: Hamilton Rating Scale for 
Depression; Ict: Individual Cognitive Therapy; Instr: Instrumental; Integr: Integrative; MADRS: Montgomery-Asberg Depression Rating Scale; RD: risk difference; RR: risk ratio; 
Sup: Supportive Therapy.
a)These rates indicate the number of patients who deteriorated (n) and the total psychotherapy and control group (N)
b) Clinical significant deterioration according to the definition of Jacobson & Truax (1991)
c) According to Speer & Swondle (1982). 
Fig. 2. Forest plot of deterioration rates in studies comparing psychotherapy for adult depression with control groups: Risk ratio's.
Table 2
Deterioration rates of psychotherapies for adult depression compared with control groups: risk ratios, risk differences and numbers-needed-to-be-treateda).
Nc RR 95% CI I2 95% CI p RD 95% CI NNT
All comparisons 23 0.39 0.27–0.57 0 0–40 0.05 0.03–0.07 20
One comparison per study (only highest) 18 0.35 0.22–0.54 0 0–44 0.05 0.03–0.07 20
One comparison per study (only lowest) 18 0.38 0.25–0.58 0 0–44 0.05 0.03–0.07 20
Subgroup analyses
Definition of deterioration Jacobson and Truax (1991) 15 0.39 0.23–0.66 0 0–46 0.94 0.05 0.02–0.07 20
Other 8 0.38 0.22–0.66 0 0–56 0.08 0.02–0.13 13
Diagnosis Depressive disorder 12 0.48 0.23–1.01 0 0–50 0.51 0.02 −0.01–0.05 50
Above cut-off 11 0.36 0.23–0.56 0 0–51 0.07 0.04–0.09 14
Type of therapy CBT 11 0.39 0.24–0.63 0 0–51 0.98 0.06 0.03–0.09 17
Other 12 0.39 0.21–0.71 0 0–50 0.04 0.01–0.07 25
Format Individual 6 0.44 0.20–0.97 0 0–61 0.82 0.04 0.00–0.09 25
Group 11 0.41 0.24–0.71 0 0–51 0.08 0.03–0.13 13
Guided self-help 6 0.33 0.16–0.65 0 0–61 0.04 0.01–0.07 25
Control group Waiting list 13 0.44 0.24–0.81 0 0–49 0.85 0.03 0.00–0.06 33
Care as usual 5 0.35 0.17–0.71 0 0–64 0.06 0.02 to −0.10 17
Other 5 0.36 0.19–0.71 0 0–64 0.13 0.03–0.23 8
Sensitivity analyses: risk of bias
Risk of bias Low 6 0.36 0.20–0.64 0 0–61 0.70 0.05 0.01–0.09 20
At least some RoB 17 0.41 0.25–0.68 0 0–45 0.05 0.02–0.08 20
Abbreviations: CBT: cognitive behavioral therapy; CI: confidence interval; Nc: number of comparisons; RD: risk difference; RR: risk ratio; NNT: numbers-needed-to-
treat; RoB: risk of bias.
a) according to the random effects model.
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plan treatment taking possible negative consequences into account
(Linden and Schermuly-Haupt, 2014).
One of the major problems of this study was that deterioration was
measured in many different ways. It is important for future research to
develop consensus about negative effects should be measured and re-
ported, that will allow future studies to examine negative outcomes
more precisely. Future research should also develop consensus among
psychotherapy researchers that it is important to report negative out-
comes in all trial reports, regardless of these are significant or not.
Other research areas for future research include predictors of negative
outcomes, the causes of negative outcomes and the pathways leading to
them.
The results of this study should be considered in light of the lim-
itations. The first limitation is that only a small fraction of trials on
psychotherapy report deterioration rates. It is very well possible,
therefore, that these studies are not a representative sample of all stu-
dies on psychotherapy for adult depression. However, a comparison
between studies that did and those that did not report deterioration
rates did not result in significant differences between the two samples
of studies. A second limitation is the small number of trials and the
considerable proportion of studies with risk of bias, making the results
uncertain. Another limitation is that the studies used different ways to
define deterioration, making it impossible to pool the prevalence rates
across treatments and control groups.
Despite these limitations, this study showed that only a small
number of studies have examined deterioration rates, that the studies
that did report them found that deterioration is a relatively rare event,
and that rates of deterioration may be lower in psychotherapy than in
control conditions.
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